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Abstract 
Objective: Patients with repaired tetralogy of Fallot (ToF) have an increased long-
term risk of cardiovascular morbidity and mortality. Risk stratification in this 
population is difficult. Initial evidence suggests that cardiopulmonary exercise testing 
(CPET) may be helpful to risk-stratify patients with repaired ToF. 
Methods and Results: We studied 875 patients after surgical repair for ToF (358 
females, age 25.5 ± 11.7 year, range 7 – 75 years) who underwent CPET between 
1999 and 2009. During a mean follow-up of 4.1 ± 2.6 years after CPET, 30 patients 
(3.4%) died or had sustained ventricular tachycardia (VT). 225 patients (25.7%) had 
other cardiac related events (emergency admission, surgery, or catheter 
interventions). On multivariable Cox regression-analysis, %predicted peak oxygen 
uptake ( 2OV %) (p=0.001), resting QRS duration (p=0.030) and age (p<0.001) 
emerged as independent predictors of mortality or sustained VT. Patients with a 
peak 2OV  ≤65% of predicted and a resting QRS duration ≥170 ms had a 11.4-fold risk 
of death or sustained VT.  
Ventilatory efficiency expressed as 2COE V/V   slope (p<0.001), peak 2OV % (p=.001), 
QRS duration (p=.001) and age (p=0.046) independently predicted event free 
survival. 2COE V/V   slope ≥31.0, peak 2OV % ≤65% and QRS duration ≥170ms were the 
cut-off points with best sensitivity and specificity to detect an unfavourable outcome.  
Conclusions: CPET is an important predictive tool that may assist in the risk 
stratification of patients with ToF. Subjects with a poor exercise capacity in addition to 
a prolonged QRS duration have a substantially increased risk for death or sustained 
ventricular tachycardia, as well as for cardiac-related hospitalizations. 
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Introduction 
Tetralogy of Fallot (ToF) is the most common cyanotic heart defect at birth. Surgical 
improvements over the past decades have lead to an excellent long term outcome.[1] 
Nevertheless, adults with repaired ToF continue to have residual or recurrent lesions 
as well as an increased risk for right and left heart failure and sudden cardiac death. 
The exact mechanisms for late sudden death are incompletely defined but are 
probably related to both, the residual hemodynamic and electrophysiological 
substrates that act in concert.[2, 3] Pulmonary valve replacement may be required in 
patients with significant pulmonary regurgitation to avoid progressive right ventricular 
dilation and to preserve right ventricular function,[3-7] with the ultimate aim of 
improving long-term survival. 
In patients with congenital heart disease (CHD), cardiopulmonary exercise testing 
(CPET) is generally used to quantify the degree of exercise intolerance.[8-11] 
Beyond this application, increasing interest had been devoted at understanding the 
prognostic value of CPET in CHD.[5, 8, 12-14] .However, the identification of patients 
at higher risk for death or cardiac-related morbidity is challenging. In patients with 
repaired ToF, Gatzoulis et al.[3] demonstrated a relationship between prolonged 
QRS duration and sudden cardiac death. whereas Giardini et al.[5] demonstrated in a 
small cohort that peak oxygen uptake ( 2OV ) and ventilatory efficiency could be 
helpful to stratify patients regarding their risk of death and hospitalization during 
follow-up. Recent studies[15, 16] confirmed the predictive value of hemodynamic and 
cardiopulmonary parameters in patients with ToF.  
Both QRS prolongation and reduced exercise tolerance are thought to be related to 
some of the same underlying hemodynamic abnormalities. So far, there is no 
information on whether exercise variables provide any additional prognostic 
information over QRS duration, and how the information provided by the two tests 
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might integrate to provide a better risk stratification tool for patients with repaired 
ToF.  
Hence, the objective of the present study was to assess the potential value of CPET 
variables to predict survival, as well as morbidity-free survival both independently of 
and in combination with QRS-duration and demographic variables in a large cohort of 
patients after surgical ToF repair. 
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Methods 
Study design and study subjects 
This study was designed as a multicenter retrospective investigation. In seven 
European tertiary institutions all consecutive patients with tetralogy of Fallot or Fallot-
type morphology (double outlet right ventricle with sub-aortic ventricular septal defect 
and pulmonary atresia with ventricular septal defect after bi-ventricular repair) who 
were referred for a CPET as part of their routine clinical follow-up evaluation between 
1999 and 2009 were included into the study. The study was approved by the local 
ethical board (project number 2992/10). J.M. and A.H. had full access to all of the 
data in the study and take responsibility for the integrity of the data and the accuracy 
of the data analysis. All authors have read and approved to the final version of the 
manuscript. 
 
Cardiopulmonary exercise test (CPET) 
All patients underwent a symptom limited CPET either on a bicycle ergometer in 
upright position (n=503) or on a treadmill (n=372) according to the institutional 
protocol. If more then one CPET was available the first CPET with the longest follow-
up was selected.  
Baseline parameters were recorded during at least two minutes at rest. Workload 
was increased ramp wise with the aim to reach exhaustion in 8 to 12 minutes of 
exercise. For those tested on a treadmill a modified Bruce protocol was used. The 
end of the CPET was marked by symptom limitation. A 12-lead electrocardiogram 
and pulse oximetry were recorded continuously throughout the whole test. Cuff blood 
pressure was determined every two minutes. 
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The exercise test featured a breath-by-breath gas exchange analysis using a 
metabolic chart. Peak 2OV  was defined as the highest mean uptake of any 30-
second time interval during exercise. Because of age related differences in the large 
patient cohort, reference values for age, body mass, body height, and gender, were 
expressed in percentage of predicted calculated as previously described[10] for 
children less than 18 year from Cooper & Weiler-Ravell[17] and Cooper & Storer[18] 
for adults. Ventilatory efficiency ( 2COE V/V  slope) was assessed by the slope of the 
2COE V/V   curve confined to the linear part, excluding values beyond the respiratory 
compensation point. Heart rate reserve was calculated as the difference between 
peak and resting heart rate (peak heart rate – resting heart rate) / (220 - age - resting 
heart rate) for adults older than 20 years and (peak heart rate – resting heart rate) / 
(200 – resting heart rate) for patients younger than 20 years. QRS duration was 
measured at rest in the precordial leads V1 or V2.  
 
Survival status and hospitalization 
Two different end points were assessed in the present study. The primary endpoint 
consisted in the combination of all-cause mortality (used to eliminate the possibility of 
a bias arising from incorrect classification of cause of death) or occurrence of 
sustained ventricular tachycardia, recorded (and treated) by a resuscitation team or 
by an implantable cardioverter defibrillator.  
The secondary endpoint consisted in the occurrence of death or of a cardiac-related 
event, which was defined as any hospital admission directly caused by failure of the 
cardiac system needing inpatient care to correct. Examples for cardiac event were 
cardiac surgery, interventional catheterization and symptomatic arrhythmias needing 
cardioversion, electrophysiological procedure or other treatments.  
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Patients were regularly followed up for cardiac-related events at their respective 
institutions, which guaranteed that all relevant events were captured. Patients’ 
medical records were reviewed to abstract the dates and medical reasons for 
hospitalization and their status. Survival status was reconfirmed by phone interviews 
or queries of national registries.  
Regarding the secondary endpoint, patients with a cardiac event less than three 
months after the CPET were treated as censored cases at the time of the event to 
eliminate a possibility of bias arising from pre-surgical or pre-interventional CPET 
evaluation. 
 
Assessment of pulmonary regurgitation and right ventricular function 
Pulmonary regurgitation and right ventricular function were estimated by routine 
transthoracic clinical echocardiography. Pulmonary regurgitation was quantified by 
Doppler echocardiography as none/trivial, mild, moderate or severe using published 
color-coded pulsed wave Doppler criteria.[19] Right ventricular function was 
estimated from parasternal long- and short-axis views and from an apical 4-chamber 
view and quantified subjectively by the investigator as normal/enhanced, slightly 
reduced, moderately reduced, or severely reduced. 
 
Data analyses 
Data are presented as mean ± SD, or absolute numbers (percentage). Comparisons 
between subgroups were performed by unpaired t-test or chi-square tests, as 
appropriate.  
Prognostic values of variables were assessed using multivariable Cox regression. 
The variables tested to predict survival without sustained VT (primary endpoint) were 
2COE V/V   slope, peak 2OV % predicted, age at CPET, and QRS duration at rest. For 
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the secondary endpoint of event free survival we tested exercise variables ( 2COE V/V   
slope, peak 2OV % predicted, systolic blood pressure at peak exercise, heart rate 
reserve, QRS duration at rest), age at CPET, palliation before repair, age at surgical 
repair, sex, and medications. Subsequently, a receiver-operator characteristic (ROC) 
curve analysis for a 5-year follow-up was used to identify the cut-offs of the variables 
emerged from multivariable Cox regression as being associated with the end point of 
interest. Cut-off values were chosen according to the highest sum of sensitivity and 
specificity. A non-parametric random survival forest analysis based on a log-rank 
splitting rule (using the random Survival Forest R-package) was used to obtain 
predicted 5-year outcome for various combinations of QRS-duration and 2OV % 
predicted. The results are presented as contour plots with isoquants of 3-year 
outcome. 
Analyses were performed using PASW Statistics 18.0 (SPSS Inc, Chicago, Illinois, 
USA) and R version 2.12.2. P-values <0.05 in a two-sided analysis were considered 
significant. 
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Results 
Baseline characteristics of the 875 patients studied are presented in Table 1. All 
CPET were performed until maximum exhaustion resulting in a mean respiratory 
exchange ratio of 1.11 ± 0.16 and a mean peak 2OV  of 27.7 ± 8.6 ml/kg/min, 
representing 76.6 ± 19.7 % predicted (Figure 1). No patient was cyanotic at rest or 
during peak exercise. Follow-up was completed for all patients.  
 
Survival without sustained ventricular tachycardia 
During a mean follow up of 4.1 ± 2.6 years, 30 patients met the composite primary 
end-point of death or survived ventricular tachycardia at a mean age of 39.6 ± 13.0 
years. Four patients died postoperatively, three died suddenly, another three 
succumbed due to heart failure, and the cause of death could not be determined in 
eight patients. Another twelve patients survived sustained ventricular tachycardia 
and, therefore, received an ICD. Annual event rate for the primary endpoint was 0.6% 
per year. 
At multivariate Cox regression, %predicted peak 2OV  (hazard ratio [HR] 0.968, 95% 
confidence interval [CI] 0.948 to 0.988; p=0.001), QRS duration at rest (HR 1.016, CI 
1.002 to 1.030; p=0.030) and age (HR 1.058, CI 1.032 to 1.084; p<0.001) emerged 
as independent predictors of the primary outcome.  
ROC curve analysis identified a peak 2OV % ≤62.6% (sensitivity 82%, specificity 
63%) and QRS duration of ≥169.5 ms (sensitivity 53%, specificity 86%) as optimal 
cut-off values for 5 year freedom from death or ventricular arrhythmia in the dataset. 
The ROC curve for age showed no clear cut-off value but an almost linear increase of 
risk with age. 
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For clinical application, values were rounded to 65% (peak 2OV %) and 170ms (QRS 
duration) and Kaplan-Meier survival charts were generated. Survival curves suggest 
that those patients with both a peak 2OV % ≤65% and QRS-duration ≥170ms are at 
particularly higher risk for premature death (Figure 2). Indeed when compared to 
patients with no or only one risk factor, the estimated survival hazard increased by 
11.4-fold (95% confidence interval 5.5 - 23.7). In the first year after CPET, 13 of the 
60 patients (21.6%) with both risk factors had died or had a sustained ventricular 
tachycardia. The random survival forest analysis (Figure 3) included both variables 
and confirmed that the risk of death/sustained VT is highest in those patients with 
both elevated QRS duration and limited peak 2OV %. 
 
Event free survival 
The secondary composite was reached by 225 (25.7%) patients after a follow up of 
2.5 ± 2.3 years. Mean age was 31.2 ± 13.3 years. Annual event rate was 13.7% per 
year. The events are presented in detail in Figure 4.  
Those patients who reached the combined secondary end-point were significantly 
older at surgical repair, had received more surgeries before the CPET and were older 
at the time of CPET. They also had more often received a palliative procedure before 
surgical repair. In this group peak 2OV % and heart rate reserve were reduced, 
whereas 2COE V/V   slope and QRS duration was increased (Table 1).  
At multivariable Cox regression, 2COE V/V  slope (HR 1.033, CI 1.017 to 1.049; p<.001), 
peak 2OV % (HR 0.987, CI 0.979 to 0.995; p=.001), QRS duration at rest (HR 1.009, 
CI 1.003 to 1.015; p=.001) and age (HR 1.011, CI 1.010 to 1.021; p=.046) emerged 
as independent predictors for an increased risk of death or cardiac-related events.  
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At ROC analysis, a 2COE V/V  slope ≥31.0 (sensitivity 64%, specificity 67%), a peak 
2OV % ≤67.9% (sensitivity 73%, specificity 54%) and a QRS duration ≥169.5ms 
(sensitivity 31%, specificity 86%) were associated with an increased 5-year risk of 
reaching the secondary end point. Again, the ROC curve for age showed no clear 
cut-off value but an almost continuous increase of risk. 
In order to improve clinical applicability, cut-off values for peak 2OV % and QRS 
duration were rounded to 65% and 170ms, respectively. In addition a hazard score 
for the 2COE V/V  slope cut off value of 31 was calculated. Kaplan-Meier survival charts 
were generated for patient’s groups having none, one, two or all three of the above 
mentioned risk factors. The resulting survival curves show a stepwise increase in the 
event rate for every additional risk factor present (Figure 5). Patients with one risk 
factor were estimated to have a 2.7 fold hazard increased (95% confidence interval 
2.0 - 3.6), compared to patients with no risk factor. If two risk factors were present, 
hazard increased 4.4-fold (95% confidence interval 3.1 - 6.2) and in patients with all 
three risk factors hazard increased by 5.4-fold (95% confidence interval 3.3 - 8.9), 
respectively. 
For both end points, Kaplan-Meier charts showed that CPET has the best predictive 
ability for the first three years after CPET. Afterwards the risks of the groups are 
equalizing again. 
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Discussion 
This study showed that CPET is a valuable prognostic tool in patients with repaired 
Tetralogy of Fallot and its prognostic value is complementary to that provided by 
more traditional risk factors, like QRS duration. Indeed, patients who have both a 
predicted peak 2OV  ≤65% and a resting QRS duration ≥170ms have a 11.4-fold 
increased risk of dying or having a sustained VT during follow-up. We also showed 
that significant cardiac morbidity could be predicted by a peak 2OV  ≤65%, a 2COE V/V   
slope ≥31, and a resting QRS duration ≥170ms, with the risk of events increasing in a 
stepwise manner for every additional risk factor present.  
 
Predictors and cut-off values for the primary endpoint 
In Tetralogy of Fallot the majority of deaths are due to ventricular arrhythmias, 
progressive heart failure and re-operations.[4, 5, 7, 20-22] In an initial study on 
mechano-electrical interaction, Gatzoulis et al.[3] showed that QRS prolongation is 
related to increased right ventricular size and predicts malignant ventricular 
arrhythmias and sudden death. The study showed that all patients with documented 
syncope and sustained ventricular tachycardia and all patients who died suddenly 
had a QRS duration of 180ms or longer. In contrast, Khairy et al.[23] could not 
confirm a QRS duration >180ms as a risk factor for appropriate shocks in patients 
with ToF and an implanted cardioverter/defibrillator. In the cohort studied by Khairy, 
however, almost half of the patients with an ICD died from heart failure and not 
because of malignant arrhythmias. The current study based on a large sample of ToF 
patient, shows that QRS duration is an important risk factor for mortality and 
sustained ventricular arrhythmias in this patient group. The cut-off value of 170ms 
estimated from ROC curve analysis in our cohort is slightly lower than the previous 
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threshold reported by Gatzoulis et al.[3] This could be the result of different surgical 
techniques adopted in our more recent cohort, such as transatrial repairs as well as 
limited ventriculotomies that might have been performed as a result of increased 
awareness of the mechanical-electrical interactions. In addition to QRS duration, our 
study shows that risk prediction can be substantially improved by including exercise 
capacity into the prognostic model. This might be explained by the fact that 
underlying right ventricular mechanics and ECG manifestations of the abnormal right 
ventricular mechanics (QRS duration) even though clearly associated, might be not 
proportionate to each other in terms of magnitude. For example, some patients may 
have a prolonged electrical intra-ventricular delay but still a good hemodynamic 
function that is not revealed by simple ECG, like patients with extensive 
ventriculotomies but substantially preserved pulmonary valve function. This group, as 
well as some other patients with less intra-ventricular delay but a worse 
hemodynamic function, like patients with residual right ventricular outflow tract 
obstruction, showed an almost similar risk to that of patients without risk factors. This 
seems to highlight that abnormal cardiac size and function needs to be associated 
with abnormal intraventricular conduction for the risk of death to be increased in 
patients with repaired ToF. Of particular importance is also the fact that the risk 
factors identified by the present study, both old and new, seem to be complementary, 
so that risk appears to be substantially higher only in patients with both prolonged 
QRS duration and reduced exercise capacity.  
Peak 2OV  has gained attention as a prognostic tool in adults with congenital heart 
disease since Diller at el.[8] originally reported that patients with a peak 2OV  ≤15.5 
ml/kg/min are at increased risk of premature death. However, this single-center study 
was limited by the fact that different diagnostic groups had to be combined to obtain 
sufficient events for statistical analysis. Our cut-off value of peak 2OV % ≤65% is 
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much higher (about 23.6 ml/min/kg) than the one observed by Diller et al.. This 
outlines the better exercise capacity of ToF patients as a group. It also highlights the 
importance of the underlying risk profile of the population studied.  
 
Predictors and cut-off values for secondary endpoint 
Our data indicate that patients with an increased ventilatory response to exercise 
( 2COE V/V  slope ≥31.0), those with more than moderate exercise intolerance (peak 
2OV % ≤65 %) or those with a prolonged QRS duration (QRS ≥170 ms) are at higher 
risk for cardiac related events or death. We could also show that patient’s hazard 
seems to increase stepwise when more single risk factors are present in 
combination. Previous studies have already shown the usefulness of CPET 
parameters like 2COE V/V  slope, peak 2OV % and heart rate response to predict event 
free survival in patients with CHD. These studies included patients with several 
different CHD,[8, 13, 14] or single diagnostic groups like in patients with ToF,[5] 
transposition of the great arteries after atrial repair[12] or univentricular heart after 
Fontan operation.[24] Again, predictive variables and thresholds for adverse outcome 
differed according to the underlying diagnosis and the different hemodynamic 
situations. 
CPET has been previously used to predict cardiac-related outcomes in adults with 
repaired ToF[3, 5, 15]. In that study, which followed up 118 adults with repaired ToF 
for 5.8  2.3 years, Giardini et al.[5] observed that exercise capacity and ventilatory 
efficiency were able to identify a subgroup of patients at increased risk of cardiac-
related death and hospitalization. The present study, in comparison to the previous 
study included some important additional outcomes, like all cause mortality and 
pulmonary valve replacement. As a result of differences in the characteristics of the 
population studied, like the prevalence of right ventricular dysfunction, the cut-off 
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values observed by Giardini et al. ( 2COE V/V  slope >39, 2OV % ≤36%) are different from 
those observed in the present study. Despite these differences, our study, performed 
in a substantially larger patient cohort corroborates the finding that CPET is useful for 
risk stratification in ToF patients. Importantly, we could demonstrate that risk 
stratification based on the combination of CPET and QRS duration is superior to that 
based on a single test, with the sensitivity and specificity of the risk model that 
improves the more risk factors are present. 
The presented risk model may assist in clinical decision-making, with particular 
reference to procedures aiming at preserving right ventricular size and function and 
miniming the risk of late death. The beneficial effect of pulmonary valve replacement 
on QRS duration is only transient [25, 26], and prognosis is worse if there is no 
reduction in QRS duration as a result of pulmonary valve replacement.[27] The right 
timing for pulmonary valve replacement is very important and it was suggested that 
surgery should be considered early before right ventricular function deteriorates due 
to volume overload.[28-33] Also recent data show that percutaneous pulmonary valve 
implantation does not lead to any improvement if limitations in exercise capacity are 
mainly due to pulmonary regurgitation and right ventricular dilatation.[30, 33] Our 
data suggest that patients with at least moderately reduced exercise tolerance, those 
with elevated ventilatory response to exercise, and those with prolonged QRS 
duration should be investigated thoroughly to identify potentially correctable surgical 
or interventional target lesions.  
 
Limitations 
All patients were followed up at tertiary centers and a referral bias towards more 
advanced forms of the disease with more symptomatic patients cannot be excluded. 
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However, at the institutions involved, it is established clinical practice to test every 
patient with repaired ToF with CPET. Therefore, we believe that the results of our 
study can be generalized to the whole ToF patient population.  
Cardiac MRI is the gold standard for the assessment of cardiovascular 
haemodynamics after repair of ToF and recent studies linked abnormal 
haemodynamic status measured by MRI with outcome.[34] Unfortunately, MRI data 
were available in only a small proportion of subjects and for this reason they were not 
entered in the analysis. 
 
Conclusion  
Cardiopulmonary exercise testing is a valuable tool in the long-term follow-up of 
patients with Tetralogy of Fallot. It has independent, additional prognostic value on 
top of the established risk factor of QRS duration. Exercise testing should be used in 
the clinical risk stratification of patients with repaired ToF. 
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Table 1: Study subjects  
Variable 
All study 
cohort  
Survivors 
without event 
Death or 
 event  
p-value* 
(n=875) (n=650) (n=225)  
Female sex, n (%) 358 (40.9) 280 (43.1) 78 (34.7) 0.150 
Diagnosis, n (%)       
 Fallot 743 (85.0) 548 (84.3) 195 (86.7) 
0.229 
 DORV 73 (8.3) 57 (8.8) 16 (7.1) 
 PA-VSD 35 (4.0) 24 (3.7) 11 (4.9) 
 PA-VSD-Mapca 24 (2.7) 21 (3.2) 3 (1.3) 
Palliation, n (%)       
 None 558 (63.8) 434 (66.8) 124 (55.1) 
0.002 
 BT-shunt 188 (21.5) 134 (20.6) 54 (24.0) 
 AP-shunt 88 (10.1) 56 (8.6) 32 (14.2) 
 Other 41 (4.6) 26 (4.0) 15 (6.7) 
Age at surgical repair (years) 5.3 ± 6.5 4.9 ± 6.0 6.5 ± 7.8 0.004 
Type of corrective surgery (n=688) (n=534) (n=154)  
 Infundibulectomy/Commisurotomy 268 (38.5) 213 (39.9) 55 (35.7) 
0.682 
 Transvalvular patch  284 (41.9) 213 (39.9) 71 (46.1) 
 Unvalved conduit 36 (5.3) 28 (5.2) 8 (5.2) 
 Biovalved conduit 97 (13.9) 77 (14.4) 20 (13.0) 
 Mechanical valved conduit 3 (0.4) 3 (0.6) - 
Cardiac surgeries after initial repair, 
but before CPET (n=662) (n=527) (n=135)  
 None 413 (62.0) 338 (64.1) 75 (55.6) 
0.042  One 222 (33.9) 167 (31.7) 55 (40.7) 
 Two or more 27 (4.1) 22 (4.2) 5 (3.7) 
Interventional heart catheter after 
initial repair, but before CPET (n=875)  (n=650) (n=225)  
 None 777 (88.3) 575 (88.5) 197 (87.6) 
0.864  One 81 (9.3) 60 (9.2) 21 (9.3) 
 Two or more 22 (2.4) 15 (2.3) 7 (3.1) 
Electro physical procedures after 
initial repair, but before CPET (n=875)  (n=650) (n=225)  
 Ablation/cardioversion 36 (4.0) 23 (3.6) 13 (5.8) 
0.115 
 Pacer/ICD implant 19 (2.1) 12 (1.8) 7 (3.1) 
Age at CPET (years) 25.5 ± 11.7 24.3 ± 11.0 29.2 ± 12.9   <0.001 
Pulmonary regurgitation (n=853) (n=632) (n=221)  
 Absent/trivial 227 (26.0) 192 (30.4) 35 (15.8) 
<0.001 
 Mild  188 (21.5) 161 (25.5) 27 (12.2) 
 Moderate  198 (22.6) 148 (23.4) 50 (22.6) 
 Severe 240 (27.4) 131 (20.7) 109 (49.3) 
Right ventricular function (n=858) (n=636) (n=222)  
 Normal/enhanced 542 (61.9) 421 (66.2) 121 (54.5) 
<0.001 
 Slightly reduced 228 (26.1) 166 (26.1) 62 (27.9) 
 Moderately reduced 64 (7.3) 36 (5.7) 28 (12.6) 
 Severely reduced 24 (2.7) 13 (2.0) 11 (5.0) 
Peak oxygen uptake      
 ml/min/kg 27.7 ± 8.6 28.6 ± 8.6 25.2 ± 8.5 <0.001 
 % of predicted 76.6 ± 19.7 78.3 ± 18.6 71.8 ± 21.6 <0.001 
2COE V/V  -slope 30.5 ± 7.3 29.8 ± 6.5 32.7 ± 9.7 <0.001 
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Peak systolic blood pressure, mmHg  151 ± 28 152 ± 27 149 ± 29 0.085 
Heart rate reserve, % 76 ± 19 77 ± 18 74 ± 20 0.015 
QRS duration at rest, ms 145 ± 27 143 ± 26 153 ± 28 <0.001 
Respiratory exchange ratio 1.11 ± 0.16 1.11 ± 0.41 1.09 ± 0.11  0.248 
Medication, n (%)      
 Beta-blocker 55 (6.3) 39 (6.0) 16 (7.1) 0.363 
 Antiarrhythmic agents 49 (5.7) 23 (3.8) 26 (11.5) <0.001 
 ACE inhibitors 52 (5.9) 28 (4.4) 24 (10.7) <0.001 
 Diuretic 51 (5.8) 24 (3.8) 27 (12.0) <0.001 
 
* Comparison of the subgroups (survivors without event vs. death or event) by a t-
test or Chi square test. 
DORV: Double Outlet Right Ventricle, PA-VSD Pulmonary Atresia with Ventricular 
Septal Defect, MAPCA: Major aortopulmonary collateral artery, BT-Shunt: Blalock-
Taussig shunt, AP-shunt: Aortopulmonary-shunt, CPET: cardiopulmonary exercise 
test, ICD: implantable cardioverter-defibrillator 
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Figure 1: Distribution of peak oxygen uptake expressed as percentage of predicted value in 875 patients with Tetralogy of Fallot. 
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Figure 2: Kaplan-Meier survival curves according to the presence or absence of peak 
2OV  ≤65% predicted and resting QRS duration ≥170 ms. Results suggest that only 
those patients with both risk factors are at high risk for death or sustained ventricular 
tachycardia during follow-up. 
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Figure 3: Predicted 5-year risk of death or sustained ventricular tachycardia based on 
the results of a random survival forest analysis (see Methods for 
details).
Patients with VT or deaths are marked in black  
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Figure 4: Flow chart describing the types of first cardiac related event observed after 
cardiopulmonary exercise testing (CPET)  
 
EPS: Intracardiac electrophysiology study, ICD: Implantable Cardioverter/Defibrillator, PPVI: 
Percutaneous Pulmonary Valve Implantation 
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Figure 5: Kaplan-Meier curve showing freedom from the secondary end point 
according to the numbers of risk factors (peak 2OV  ≤65% predicted, 2COE V/V   slope 
≥31, resting QRS duration ≥170ms) showing that risk increases for every additional 
factor present. 
 
